Voice your opinion on congressional bill S2051-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Strengthening Average Sales Price Reporting Act of 2019

This bill requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.

HR2113-116, HR2296-116, HR19-116, HR2087-116, S3129-116, HR1570-116,

Senate Actions

IntroReferral
Jun. 28 2019	Read twice and referred to the Committee on Finance.

Library of Congress Actions

IntroReferral
Jun. 28 2019	Introduced in Senate

Senate bill S2051-116

Strengthening Average Sales Price Reporting Act of 2019

Promote the cause!

Or use this QR code